secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELUTIA INC. (ELUT)
CIK:        0001708527
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001104659-22-124337
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aziyo Biologics offers 2.35M shares at $4.75, netting ~$9.84M; gets $4M loan
----------------------------------------------------------------------------

- Public offering of 2,350,000 shares at $4.75/share; expected net proceeds ~$9.84M after discounts and expenses.
- Underwriter Cantor Fitzgerald granted 30-day option to purchase up to 352,500 additional shares.
- Credit agreement amended to allow $4M term loan subject to equity raise of at least $10M net proceeds (satisfied by offering).
- Proceeds planned for product development, clinical research, sales hiring, and working capital.
- Loan amendment also requires Aziyo to make Chief Scientific Officer available for FDA status discussions on CanGaroo RM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708527/000110465922124337/0001104659-22-124337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708527/000110465922124337/tm2231343d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-124337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer